Technology News and Research

RSS

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Multiple myeloma is the second most common type of blood cancer in the United States, impacting more than 25,000 people each year and disproportionatly affecting African-American men.

15 May 2018

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

Children who underwent cardiac surgery were less likely to develop acute kidney injury if they had been treated with acetaminophen in the first 48 hours after their procedures, according to a Vanderbilt study just published in JAMA Pediatrics.

15 May 2018

UTA bioengineering professor successfully patents new cancer trap

The University of Texas at Arlington has successfully patented in Europe an implantable medical device that attracts and kills circulating cancer cells that was invented by a faculty member. This cancer trap can be used for early diagnosis and treatment of metastasized cancer.

14 May 2018

Scientists design new computational strategy to enable more personalized cancer treatment

Mathematicians and cancer scientists have found a way to simplify complex biomolecular data about tumors, in principle making it easier to prescribe the appropriate treatment for a specific patient.

14 May 2018

Protein researchers identify several new potential targets for cancer

In a new study based on mouse cells internationally leading protein researchers have identified several new potential targets using state-of-the-art technology, many of which could be employed for future treatment of different types of cancers and diseases.

14 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe medicines with lasting therapeutic benefit for children with life-threatening diseases, today announced it will be presenting data on the company's technology and robust preclinical pipeline at the annual meeting of the American Society of Gene & Cell Therapy at the Hilton Chicago, from May 16-19, 2018.

14 May 2018

Ohio students to showcase their creative solutions for ending heart disease

On May 15, Ohio students from 19 schools will gather at Battelle to showcase their creative solutions to ending heart disease.

14 May 2018

Havard University grants license to Beam Therapeutics to develop new base editing technology

Harvard University has granted a worldwide license to Beam Therapeutics, Inc., to develop and commercialize a suite of revolutionary DNA base editing technologies for the treatment of human disease.

14 May 2018

Sticker shock jolts Oklahoma patient: $15,076 for four tiny screws

Sherry Young just wanted to be able to walk without pain. About three years ago, she began to experience sharp pain in her left foot. Her big toe had become crooked and constantly rubbed up against the adjacent toe, making it painful to run, walk or even stand. "I could not walk without intense pain unless I had a pad underneath my toes for cushioning," Young said.

14 May 2018

New technique aims to expand understanding of mechanical forces existing between cells

A new technique that uses tiny elastic balls filled with fluorescent nanoparticles aims to expand the understanding of the mechanical forces that exist between cells, researchers report.

14 May 2018

Doctors use new non-invasive approach to treat nasal obstruction

Researchers at The Ohio State University Wexner Medical Center are exploring how small changes in the nasal cavity impact airflow and quality of life.

14 May 2018

Study: Learning a second language can change sensory perception

Learning a second language can change the way our senses work together to interpret speech, according to a new Northwestern University study.

14 May 2018

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

President Donald Trump didn't mention Novartis or other drugmakers by name last year when he said the industry is "getting away with murder."

11 May 2018

CRISPR-based treatment can restore retinal function in mice with eye disease

Researchers from Columbia University have developed a new technique for the powerful gene editing tool CRISPR to restore retinal function in mice afflicted by a degenerative retinal disease, retinitis pigmentosa.

11 May 2018

UAB expert highlights need to do more trials in the epidemic center of disease

Frances Lund, Ph.D., the Charles H. McCauley Chair of Microbiology at the University of Alabama at Birmingham, spoke about chronic inflammatory disease and the striking correlation between location and disease incidence at the recent Fourth International Vatican Conference, "Unite to Cure."

11 May 2018

Study validates accuracy of smart watches in measuring rapid heart rate

A new study is the first to validate the accuracy of wrist-worn wearable devices in measuring induced paroxysmal supraventricular tachycardia (PSVT), or episodes of rapid heart rate.

11 May 2018

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

HORIBA UK Ltd, Medical announces a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

From HORIBA Medical 11 May 2018

Faster detection, treatment of anemia made possible with production of new portable diagnostic device

Faster detection and treatment for blood conditions such as anemia has come a step closer with the production of a new device in the UK for medical technology company Entia Ltd.

11 May 2018

Huron announces collaboration with UPMC and abstract presentation at Pathology Informatics Summit

Huron Digital Pathology announced today that Dr. Hamid Tizhoosh, Director of the KIMIA Lab at the University of Waterloo and Huron advisory board member, will present a talk entitled “Faster, Better, More Reliable than Deep Features: A Projection-Based, Pathologist-Centric Approach to Identification of Histopathology Images” at the Pathology Informatics Summit on May 22, 2018 in Pittsburgh, PA.

From Huron Technologies 11 May 2018

Technology News and Research

UAB-led clinical trial intends to find innovative treatment for multiple myeloma patients

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

UTA bioengineering professor successfully patents new cancer trap

Scientists design new computational strategy to enable more personalized cancer treatment

Protein researchers identify several new potential targets for cancer

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

LogicBio team to present data on preclinical effectiveness of GeneRide platform

Ohio students to showcase their creative solutions for ending heart disease

Havard University grants license to Beam Therapeutics to develop new base editing technology

Sticker shock jolts Oklahoma patient: $15,076 for four tiny screws

New technique aims to expand understanding of mechanical forces existing between cells

Doctors use new non-invasive approach to treat nasal obstruction

Study: Learning a second language can change sensory perception

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

CRISPR-based treatment can restore retinal function in mice with eye disease

UAB expert highlights need to do more trials in the epidemic center of disease

Study validates accuracy of smart watches in measuring rapid heart rate

HORIBA Medical introduces new Yumizen G range to extend Hematology portfolio

Faster detection, treatment of anemia made possible with production of new portable diagnostic device

Huron announces collaboration with UPMC and abstract presentation at Pathology Informatics Summit

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News